Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to prevent early graft dysfunction in orthotopic liver transplantation
ChiCTR2300079022Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Orthotopic liver transplantation (OLT) and Early allograft dysfunction (EAD) comparing Tranexamic acid group with Control group (normal saline placebo) (2 arms). Primary endpoint: Incidence of early allograft dysfunction. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Orthotopic liver transplantation (OLT)Early allograft dysfunction (EAD)
Beyond the preview
Go deeper on ChiCTR2300079022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079022.